Prostacyclin — CAS 35121-78-9

Prostacyclin (Epoprostenol / PGI2) is a naturally occurring prostaglandin and potent vasodilator and inhibitor of platelet aggregation. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. It is used in the treatment of pulmonary arterial hypertension and is also employed during cardiopulmonary bypass to prevent platelet aggregation.

• Treatment of pulmonary arterial hypertension (PAH)
• Prevention of platelet aggregation during extracorporeal circulation
• Antiplatelet therapy in peripheral vascular disease
• Research applications in cardiovascular and thrombosis studies

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support